Liftstream Life Science Newsletter August Edition
The August edition of the newsletter contains > Finance funding and industry news including a round-up of recent events in the Duchenne Muscular Dystrophy market, Ipsen completing the purchase of...
View ArticlePfizer gains experimental drug from Gliknik
Authored by James Sheppard Global pharmaceutical giant Pfizer has signed a deal with tiny US biotech Gliknik for the experimental drug GL-2045. GL-2045 is being developed for the treatment of...
View ArticleNPS Pharma submits BLA for Natpara
Authored by James Sheppard US rare disease specialist NPS Pharmaceuticals announced that it has submitted a Biologic License Application (BLA) to the US FDA for Natpara. The product is a bioengineered...
View ArticleDiversity agenda still lagging in the biotechnology market
Authored by Karl Simpson October saw the release of the new World Economic Forum’s report on the Global Gender Gap. Once again, the list of top 10 places to be a woman in business seems to be dominated...
View ArticleLiftstream marks 10th anniversary
Authored by Karl Simpson January 2014 was a key month at Liftstream HQ. On the 7th January, Liftstream reached a key milestone in its existence, a full 10 years since our incorporation. It was a great...
View ArticleEuropean Executive Women Influencing Life Science Industries
Authored by Karl Simpson Many of the challenges relating to gender diversity have been difficult to overcome because they have remained buried, rather than discussed in an open and pragmatic debate....
View ArticleMerck Serono continues impressive standard in gender diversity
Authored by Karl Simpson Merck Serono has quickly become a standard-bearer for gender diversity in the pharmaceutical sector. In recent studies it has been shown that the pharmaceutical sector is...
View ArticleSanofi appoint Chief Patient Officer
Authored by James Sheppard The French pharmaceutical giant Sanofi recently announced that it had appointed Dr Anne C. Beal as its new Chief Patient Officer. This is a new role within Sanofi and one...
View ArticleEuropean biotech clusters must attract executive talent or seek new leaders
Authored by Karl Simpson In pursuit of scientific progress aimed at improving healthcare for society, the industry has gone global. Researchers, academics and industrial partners have collaborated...
View ArticleHow can biotech enhance executive leadership?
Take our short survey and participate in a global gender diversity study Working in biotech, pharma or venture capital? – Board-level directors and investors – Entry level, through...
View Article
